Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes OrganizationsFrancesco Rubino, Bruce M. Wolfe, David M. Nathan et al.|Diabetes Care|2016Cited by 969
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analysesNatalie Nanayakkara, Sophia Zoungas, Andrea J. Curtis et al.|Diabetologia|2020Cited by 373
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trialJohannes F.E. Mann, Katherine R. Tuttle, David M. Charytan et al.|Nature Medicine|2024Cited by 152
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysisFang Lv, Linong Ji, Xiaoling Cai et al.|Bone|2019Cited by 110
Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trialHiddo J.L. Heerspink, Janet B. McGill, Andreas L. Birkenfeld et al.|Diabetes Research and Clinical Practice|2023Cited by 57